Jennifer Dyer
Pediatric Endocrinology · Columbus, OHNPI 1932121480
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Dexcom, Inc. at 49.7% of the total. Reporting peaked in 2023 at $23,992 and has fallen 99.9% since, to $23 in 2025. Among pediatric endocrinology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $246.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$35K
- Xeris Pharmaceuticals, Inc.$16K
- Tandem Diabetes Care, Inc.$8K
- Sanofi-aventis U.S. LLC$8K
- Insulet Corporation$831
- Mannkind Corporation$625
- plus $2K from 13 others
What the payments were for
- Consulting fees$15,57922%
- Speaking & faculty fees$40,61157%
- Travel & lodging$5,7038%
- Food & beverage$8,98913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 101 | $35,233 |
| Xeris Pharmaceuticals, Inc. | 32 | $16,143 |
| Tandem Diabetes Care, Inc. | 38 | $8,281 |
| Sanofi-aventis U.S. LLC | 8 | $8,079 |
| Insulet Corporation | 24 | $831 |
| Mannkind Corporation | 18 | $625 |
| Novo Nordisk | 13 | $425 |
| AbbVie | 20 | $408 |
| Pfizer | 15 | $211 |
| Zealand Pharma US, Inc. | 2 | $163 |
| Lilly USA, LLC | 7 | $134 |
| BETA Bionics, Inc. | 1 | $130 |
| Cequr Corporation | 2 | $68 |
| Valeritas, Inc. | 1 | $37 |
| Medtronic | 2 | $33 |
| Companion Medical, Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$18,755
- GVOKE HYPOPEN$15,236
- DEXCOM G6 CGM SYSTEM$11,143
- TZIELD$7,979
- t:slim X2 insulin pump$4,450
- t-slim insulin pump$3,450
- DEXCOM CGM$2,341
- GVOKE PFS$570
- iLet Bionic Pancreas$389
- Ozempic$245
- AFREZZA$226
- ZEGALOGUE$139
- t:slim X2 Insulin Pump with Control-IQ$113
- Omnipod$109
How this compares
$70,882 in reported general payments places this provider in the 95th percentile of 76 pediatric endocrinology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 20 | $427 |
| Metformin Hcl ErMetformin Hcl | 11 | $141 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Columbus
- Sasigarn BowdenColumbus$16K
- Kathryn ObrynbaColumbus$11K
- Rolando LozanoColumbus$8K
- Leena NahataColumbus$3K
- Robert HoffmanColumbus$1K
- Leanne SancrainteColumbus$425
- Manmohan KambojColumbus$179
- Philippe BackeljauwCincinnati$632K
- Andrew DauberCincinnati$192K
- Nana Hawa Yayah JonesCincinnati$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.